Related Experiment Videos
Intrathecal baclofen in pain management
Marc Slonimski1, Stephen E Abram, Robert E Zuniga
1Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA
Regional Anesthesia and Pain Medicine
|May 13, 2004
Summary
Intrathecal baclofen, a GABA(B) agonist, shows promise for managing central pain in spasticity patients. While effective for neuropathic pain, its use as a primary spinal analgesic agent requires further investigation, especially in combination therapies.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Management
Background:
- Baclofen is a GABA(B) agonist primarily used for spasticity via spinal drug delivery.
- It exhibits potent antinociceptive effects in animal models with minimal motor impairment.
- Its application as a spinal analgesic in non-spastic patients is limited.
Purpose of the Study:
- To explore the efficacy of intrathecal baclofen for pain relief.
- To review existing literature on baclofen's use in central and peripheral pain.
- To assess the potential of combination therapies involving baclofen.
Main Methods:
- Literature review of studies on intrathecal baclofen for pain.
- Analysis of animal model data regarding antinociception and motor effects.
- Examination of clinical case studies and trials.
Main Results:
- Intrathecal baclofen effectively manages central pain in spastic patients.
- Limited evidence exists for its efficacy in peripheral nociceptive or neuropathic pain.
- Combination therapy with morphine or clonidine enhances baclofen's analgesic effects.
Conclusions:
- Intrathecal baclofen is a viable option for central pain in spasticity.
- Further research is needed to establish its role in peripheral pain management.
- Combination therapies offer synergistic benefits for spinal analgesia.